DefenCath
Drug
CorMedix Inc.
Total Payments
$70,025
Transactions
1,048
Doctors
737
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $70,025 | 1,048 | 737 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $40,163 | 6 | 57.4% |
| Food and Beverage | $29,863 | 1,042 | 42.6% |
Top Doctors Receiving Payments for DefenCath — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , FNP-C | Family | Elk Grove, CA | $119.37 | 1 |
| , NP | Family | Dallas, TX | $119.33 | 1 |
| , M.D | Nephrology | San Antonio, TX | $117.82 | 4 |
| , M.D | Nephrology | San Antonio, TX | $114.64 | 2 |
| , D.O | Internal Medicine | San Antonio, TX | $113.04 | 3 |
| , MD | Nephrology | Prescott, AZ | $110.23 | 1 |
| Vinay Acharya | Nephrology | Mckinney, TX | $106.42 | 4 |
| , M.D | Internal Medicine | San Antonio, TX | $106.21 | 2 |
| , M.D | Nephrology | Gulfport, MS | $105.32 | 5 |
| Catherine Martinez | Nurse Practitioner | Gulfport, MS | $105.26 | 5 |
| , APRN-NP | Nurse Practitioner | Omaha, NE | $104.52 | 1 |
| , APRN, FNP | Nephrology | Metairie, LA | $104.17 | 5 |
| , M.D | Nephrology | New Orleans, LA | $103.26 | 5 |
| , NP | Nurse Practitioner | Murray, UT | $102.03 | 1 |
| , M.D | Nephrology | West Hollywood, CA | $101.87 | 1 |
| Maria Brant | Adult Health | West Hollywood, CA | $101.87 | 1 |
| , M.D | Nephrology | Dallas, TX | $100.13 | 4 |
| , M.D | Nephrology | San Antonio, TX | $100.07 | 3 |
| , ARNP | Acute Care | Miami, FL | $98.57 | 1 |
| Annia Asencio | Nurse Practitioner | Miami, FL | $98.56 | 1 |
| , NP | Acute Care | Salt Lake City, UT | $96.78 | 1 |
| , M.D | Internal Medicine | San Antonio, TX | $94.43 | 4 |
| , M.D | Internal Medicine | El Paso, TX | $90.06 | 3 |
| , MD | Nephrology | Oklahoma City, OK | $87.73 | 3 |
| , MD | Emergency Medicine | Live Oak, TX | $87.60 | 3 |
Ad
Manufacturing Companies
- CorMedix Inc. $70,025
Product Information
- Type Drug
- Total Payments $70,025
- Total Doctors 737
- Transactions 1,048
About DefenCath
DefenCath is a drug associated with $70,025 in payments to 737 healthcare providers, recorded across 1,048 transactions in the CMS Open Payments database. The primary manufacturer is CorMedix Inc..
Payment data is available from 2024 to 2024. In 2024, $70,025 was paid across 1,048 transactions to 737 doctors.
The most common payment nature for DefenCath is "Consulting Fee" ($40,163, 57.4% of total).